Top Ad unit 728 × 90

Radiology News

radiology

New ACR guidelines on Gadolinium in End-Stage Renal Disease

Patients with any stage of renal disease should not receive the MR gadolinium contrast agent Omniscan, to help prevent a rare and life-threatening skin disease according to new, comprehensive MR Safe Practice Guidelines from the American College of Radiology.
Link to detailed guidelines here-
New ACR guidelines on Gadolinium in End-Stage Renal Disease Reviewed by Sumer Sethi on Monday, March 05, 2007 Rating: 5

1 comment:

Timeless Boulevard said...

Hi there! May I link my blog to this site? Thanks! :-)
www.ksdescartin.wordpress.com

All Rights Reserved by Sumer's Radiology Blog © 2014 - 2015
Powered By Blogger,

Contact Form

Name

Email *

Message *

All contents copyrights with Sumer Sethi. Powered by Blogger.